Are We Close to Defining a Metabolomic Signature of Human Obesity? A Systematic Review of Metabolomics Studies

Overview

Journal Metabolomics

Publisher Springer

Specialty Endocrinology

Date 2019 Jun 15

PMID 31197497

Citations 119

Authors

Oscar Daniel Rangel-Huerta

Belen Pastor-Villaescusa

Angel Gil

Affiliations

Soon will be listed here.

Abstract

Introduction: Obesity is a disorder characterized by a disproportionate increase in body weight in relation to height, mainly due to the accumulation of fat, and is considered a pandemic of the present century by many international health institutions. It is associated with several non-communicable chronic diseases, namely, metabolic syndrome, type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD), and cancer. Metabolomics is a useful tool to evaluate changes in metabolites due to being overweight and obesity at the body fluid and cellular levels and to ascertain metabolic changes in metabolically unhealthy overweight and obese individuals (MUHO) compared to metabolically healthy individuals (MHO).

Objectives: We aimed to conduct a systematic review (SR) of human studies focused on identifying metabolomic signatures in obese individuals and obesity-related metabolic alterations, such as inflammation or oxidative stress.

Methods: We reviewed the literature to identify studies investigating the metabolomics profile of human obesity and that were published up to May 7th, 2019 in SCOPUS and PubMed through an SR. The quality of reporting was evaluated using an adapted of QUADOMICS.

Results: Thirty-three articles were included and classified according to four types of approaches. (i) studying the metabolic signature of obesity, (ii) studying the differential responses of obese and non-obese subjects to dietary challenges (iii) studies that used metabolomics to predict weight loss and aimed to assess the effects of weight loss interventions on the metabolomics profiles of overweight or obese human subjects (iv) articles that studied the effects of specific dietary patterns or dietary compounds on obesity-related metabolic alterations in humans.

Conclusion: The present SR provides state-of-the-art information about the use of metabolomics as an approach to understanding the dynamics of metabolic processes involved in human obesity and emphasizes metabolic signatures related to obesity phenotypes.

Citing Articles

The multi-omics signatures of telomere length in childhood.

Wang C, Martens D, Bustamante M, Alfano R, Plusquin M, Maitre L BMC Genomics. 2025; 26(1):75.

PMID: 39871190 PMC: 11771044. DOI: 10.1186/s12864-025-11209-5.

Triglyceride/high-density cholesterol ratio as a predictor of cardiometabolic risk in young population.

Mederos-Torres C, Diaz-Burke Y, Munoz-Almaguer M, Garcia-Zapien A, Uvalle-Navarro R, Gonzalez-Sandoval C J Med Life. 2024; 17(7):722-727.

PMID: 39440341 PMC: 11493158. DOI: 10.25122/jml-2024-0117.

Sarcosine, Trigonelline and Phenylalanine as Urinary Metabolites Related to Visceral Fat in Overweight and Obesity.

Gurgel A, Batista A, de Paiva Cavalcanti D, Magalhaes A, Zantut-Wittmann D Metabolites. 2024; 14(9).

PMID: 39330498 PMC: 11434364. DOI: 10.3390/metabo14090491.

Barriers to a Healthy Lifestyle Among Obese Patients Attending Primary Care Clinics in Al-Ahsa, Saudi Arabia.

Almohammedsaleh A, Alshawaf Y, Alqurayn A Cureus. 2024; 16(9):e69036.

PMID: 39262931 PMC: 11390142. DOI: 10.7759/cureus.69036.

Metabolomic profiles of incident gallstone disease.

Uche-Anya E, Ha J, Balasubramanian R, Rexrode K, Chan A BMJ Open Gastroenterol. 2024; 11(1).

PMID: 39209332 PMC: 11367368. DOI: 10.1136/bmjgast-2024-001417.

References

Putri S, Yamamoto S, Tsugawa H, Fukusaki E . Current metabolomics: technological advances. J Biosci Bioeng. 2013; 116(1):9-16. DOI: 10.1016/j.jbiosc.2013.01.004. View

Tulipani S, Palau-Rodriguez M, Minarro Alonso A, Cardona F, Marco-Ramell A, Zonja B . Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes. Clin Chim Acta. 2016; 463:53-61. DOI: 10.1016/j.cca.2016.10.005. View

Fiehn O, Garvey W, Newman J, Lok K, Hoppel C, Adams S . Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One. 2010; 5(12):e15234. PMC: 3000813. DOI: 10.1371/journal.pone.0015234. View

Remedios C, Shah M, Bhasker A, Lakdawala M . Hyperuricemia: a reality in the Indian obese. Obes Surg. 2012; 22(6):945-8. DOI: 10.1007/s11695-012-0655-7. View

Marco-Ramell A, Tulipani S, Palau-Rodriguez M, Gonzalez-Dominguez R, Minarro A, Jauregui O . Untargeted Profiling of Concordant/Discordant Phenotypes of High Insulin Resistance and Obesity To Predict the Risk of Developing Diabetes. J Proteome Res. 2018; 17(7):2307-2317. DOI: 10.1021/acs.jproteome.7b00855. View

Xie G, Ma X, Zhao A, Wang C, Zhang Y, Nieman D . The metabolite profiles of the obese population are gender-dependent. J Proteome Res. 2014; 13(9):4062-73. PMC: 6098236. DOI: 10.1021/pr500434s. View

Taneli F, Ersoy B, Ozhan B, Calkan M, Yilmaz O, Dinc G . The effect of obesity on testicular function by insulin-like factor 3, inhibin B, and leptin concentrations in obese adolescents according to pubertal stages. Clin Biochem. 2010; 43(15):1236-40. DOI: 10.1016/j.clinbiochem.2010.07.026. View

Casson P, Toth M, Johnson J, Stanczyk F, Casey C, Dixon M . Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab. 2010; 95(9):4276-82. PMC: 2936067. DOI: 10.1210/jc.2009-2390. View

De Pergola G, Triggiani V, Giorgino F, Cospite M, Garruti G, Cignarelli M . The free testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int J Obes Relat Metab Disord. 1994; 18(10):659-64. View

10.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

11.

Kim Y, Huh I, Kim J, Park S, Ryu S, Kim K . Integration of Traditional and Metabolomics Biomarkers Identifies Prognostic Metabolites for Predicting Responsiveness to Nutritional Intervention against Oxidative Stress and Inflammation. Nutrients. 2017; 9(3). PMC: 5372896. DOI: 10.3390/nu9030233. View

12.

Barrett-Connor E, Ferrara A . Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab. 1996; 81(1):59-64. DOI: 10.1210/jcem.81.1.8550794. View

13.

Du F, Virtue A, Wang H, Yang X . Metabolomic analyses for atherosclerosis, diabetes, and obesity. Biomark Res. 2013; 1(1):17. PMC: 4177614. DOI: 10.1186/2050-7771-1-17. View

14.

Eid H, Arnesen H, Hjerkinn E, Lyberg T, Seljeflot I . Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism. 2004; 53(12):1574-9. DOI: 10.1016/j.metabol.2004.06.026. View

15.

Gil A, Aguilera C, Gil-Campos M, Canete R . Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr. 2007; 98 Suppl 1:S121-6. DOI: 10.1017/S0007114507838050. View

16.

Halford J, Harrold J, Lawton C, Blundell J . Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr Drug Targets. 2005; 6(2):201-13. DOI: 10.2174/1389450053174550. View

17.

Romo-Hualde A, Huerta A, Gonzalez-Navarro C, Ramos-Lopez O, Moreno-Aliaga M, Martinez J . Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women. Lipids Health Dis. 2018; 17(1):103. PMC: 5941619. DOI: 10.1186/s12944-018-0750-4. View

18.

Chen S, Bin P, Ren W, Gao W, Liu G, Yin J . Alpha-ketoglutarate (AKG) lowers body weight and affects intestinal innate immunity through influencing intestinal microbiota. Oncotarget. 2017; 8(24):38184-38192. PMC: 5503525. DOI: 10.18632/oncotarget.17132. View

19.

Barber M, Risis S, Yang C, Meikle P, Staples M, Febbraio M . Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One. 2012; 7(7):e41456. PMC: 3405068. DOI: 10.1371/journal.pone.0041456. View

20.

Hernandez-Alonso P, Giardina S, Canueto D, Salas-Salvado J, Canellas N, Bullo M . Changes in Plasma Metabolite Concentrations after a Low-Glycemic Index Diet Intervention. Mol Nutr Food Res. 2018; 63(1):e1700975. DOI: 10.1002/mnfr.201700975. View